Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03880292




Registration number
NCT03880292
Ethics application status
Date submitted
13/03/2019
Date registered
19/03/2019
Date last updated
21/11/2022

Titles & IDs
Public title
Spinal Deformity Intraoperative Monitoring.
Scientific title
SDIM: Spinal Deformity Intraoperative Monitoring. Understanding and Managing Intraoperative Neuromonitoring Changes During Spinal Deformity Surgery: a Prospective Interventional Study
Secondary ID [1] 0 0
SDIM
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Spinal Deformity 0 0
Condition category
Condition code
Human Genetics and Inherited Disorders 0 0 0 0
Other human genetics and inherited disorders
Reproductive Health and Childbirth 0 0 0 0
Fetal medicine and complications of pregnancy

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Surgery - Document intraoperative Maneuvers

Other: Intraoperative Maneuvers - To document intraoperative maneuvers performed in repsonse to alerts


Treatment: Surgery: Document intraoperative Maneuvers
Monitoring procedure during surgery
Intervention code [1] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Number of intraoperative neuromontoring alerts
Timepoint [1] 0 0
Intraoperative
Secondary outcome [1] 0 0
Intraoperative monitoring alert
Timepoint [1] 0 0
Intraoperative
Secondary outcome [2] 0 0
Success rate of reversal maneuvers to restore signal above the threshold
Timepoint [2] 0 0
Intraoperative
Secondary outcome [3] 0 0
Neurological status
Timepoint [3] 0 0
Baseline up to 30 days postoperative
Secondary outcome [4] 0 0
Timing of intraoperative monitoring alerts
Timepoint [4] 0 0
Intraoperative

Eligibility
Key inclusion criteria
* Age >10 years to <80 years
* Neurologically intact spinal cord (with or without radiculopathy)
* Undergoing primary or revision procedure in the spine
* Anterior and/or posterior surgical approach for any of the following:

* Correction of spinal deformity with a major Cobb angle of = 80° in the coronal or sagittal plane
* Correction of high grade spondylolisthesis (Grades 3- 5)
* Posterior column or 3-column osteotomy
* Requiring multimodal neuromonitoring with EMG, SSEP, and MEP as per standard of care
* Informed consent obtained for patients i.e.:

* Ability to understand the content of the patient information
* Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
* Signed and dated EC/IRB approved written informed consent OR
* Written consent obtained according to defined and IRB/EC approved procedures for patients who are not able to provide independent written informed consent
Minimum age
10 Years
Maximum age
80 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
• Neurodegenerative disease

* Upper motor neuron lesion
* Growing rods or growth guidance procedures
* Tether or staple procedures
* Stand-alone cervical deformity correction procedures
* Any not medically managed severe systemic disease
* Recent history of substance abuse (ie recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy or women planning to conceive within the study period
* Prisoner
* Participation in any other medical device or medicinal product study that could influence the results of the present study

Study design
Purpose of the study
Diagnosis
Allocation to intervention
NA
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
15/05/2019
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/11/2022
Sample size
Target
Accrual to date
Final
569
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Royal North Shore Hospital - Saint Leonards
Recruitment postcode(s) [1] 0 0
2065 - Saint Leonards
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Minnesota
Country [3] 0 0
United States of America
State/province [3] 0 0
New York
Country [4] 0 0
United States of America
State/province [4] 0 0
North Carolina
Country [5] 0 0
United States of America
State/province [5] 0 0
Virginia
Country [6] 0 0
Brazil
State/province [6] 0 0
Florianópolis
Country [7] 0 0
Brazil
State/province [7] 0 0
São Paulo
Country [8] 0 0
Canada
State/province [8] 0 0
Montréal
Country [9] 0 0
Canada
State/province [9] 0 0
Toronto
Country [10] 0 0
China
State/province [10] 0 0
Nanjing
Country [11] 0 0
Hong Kong
State/province [11] 0 0
Hong Kong
Country [12] 0 0
India
State/province [12] 0 0
Guntur
Country [13] 0 0
India
State/province [13] 0 0
Kolkata
Country [14] 0 0
Israel
State/province [14] 0 0
Tel Aviv
Country [15] 0 0
Japan
State/province [15] 0 0
Hamamatsu
Country [16] 0 0
Netherlands
State/province [16] 0 0
Nijmegen
Country [17] 0 0
Pakistan
State/province [17] 0 0
Lahore
Country [18] 0 0
Spain
State/province [18] 0 0
Barcelona
Country [19] 0 0
Turkey
State/province [19] 0 0
Istanbul
Country [20] 0 0
United Kingdom
State/province [20] 0 0
London
Country [21] 0 0
United Kingdom
State/province [21] 0 0
Manchester
Country [22] 0 0
United Kingdom
State/province [22] 0 0
Nottingham

Funding & Sponsors
Primary sponsor type
Other
Name
AO Foundation, AO Spine
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT03880292